References
- WHO. Obesity and overweight.2021. Accessed09 11 2021; Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
- Blüher. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288–298.
- Gadde KM, Martin CK, Berthoud H-R, et al. Obesity: pathophysiology and management. J Am Coll Cardiol. 2018;71(1):69–84.
- Nguyen NT, Varela. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol. 2017;14(3):160–169.
- Arterburn DE, Courcoulas. Bariatric surgery for obesity and metabolic conditions in adults. BMJ. 2014;349:g3961.
- McArdle MA, Finucane OM, Connaughton RM, et al. Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Front Endocrinol (Lausanne). 2013;4:52.
- Keshavjee SH, Schwenger KJP, Yadav J, et al. Factors affecting metabolic outcomes post bariatric surgery: Role of adipose tissue. J Clin Med. 2021;10(4):714.
- Lefere S, Onghena L, Vanlander A, et al. Bariatric surgery and the liver-Mechanisms, benefits, and risks. Obes Rev. 2021;22(9):e13294.
- Albers PH, Bojsen-Møller KN, Dirksen C, et al. Enhanced insulin signaling in human skeletal muscle and adipose tissue following gastric bypass surgery. Am J Physiol Regul Integr Comp Physiol. 2015;309(5):R510–524.
- Andersen CJ, Murphy KE, Fernandez. Impact of obesity and metabolic syndrome on immunity. Adv Nutr. 2016;7(1):66–75.
- Liu R, Nikolajczyk. Tissue immune cells fuel obesity-associated inflammation in adipose tissue and beyond. Front Immunol. 2019;10:1587.
- Huaizhu W, Ballantyne. Skeletal muscle inflammation and insulin resistance in obesity. J Clin Invest. 2017;127(1):43–54.
- Romeo Villarreal-Calderón J, Cuéllar RX, Ramos-González MR, et al. Interplay between the adaptive immune system and insulin resistance in weight loss induced by bariatric surgery. Oxid Med Cell Longev. 2019;2019:3940739.
- Song Y, Zhang J, Wang H, et al. A novel immune-related genes signature after bariatric surgery is histologically associated with non-alcoholic fatty liver disease. Adipocyte. 2021;10(1):424–434.
- Ji Y, Lee H, Kaura S, et al. Effect of bariatric surgery on metabolic diseases and underlying mechanisms. Biomolecules. 2021;11(11):1582.
- Goossens GH, Johan WEJ, Blaak. Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver. Nat Rev Endocrinol. 2021;17(1):47–66.
- To Yeung Y, Aziz F, Guerrero-Castilla A, et al. Signaling pathways in inflammation and anti-inflammatory therapies. Curr Pharm Des. 2018;24(14):1449–1484.
- Eder K, Baffy N, Falus A, et al. The major inflammatory mediator interleukin-6 and obesity. Inflamm Res. 2009;58(11):727–736.
- Ross SH, Cantrell. Signaling and function of interleukin-2 in T lymphocytes. Annu Rev Immunol. 2018;36:411–433.
- Kochumon S, Al Madhoun A, Al-Rashed F, et al. Elevated adipose tissue associated IL-2 expression in obesity correlates with metabolic inflammation and insulin resistance. Sci Rep. 2020;10(1):16364.
- Faramia J, Ostinelli G, Drolet-Labelle V, et al. Metabolic adaptations after bariatric surgery: adipokines, myokines and hepatokines. Curr Opin Pharmacol. 2020;52:67–74.
- Mraz M, Haluzik. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol. 2014;222(3):R113–127.
- Guzik TJ, Skiba DS, Touyz RM, et al. The role of infiltrating immune cells in dysfunctional adipose tissue. Cardiovasc Res. 2017;113(9):1009–1023.
- Kazankov K, Mark Dahl Jørgensen S, Louise Thomsen K, et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol. 2019;16(3):145–159.
- Breuer DA, Pacheco MC, Washington MK, et al. CD8+ T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol. 2020;318(2):G211–G224.
- Pillon NJ, Bilan PJ, Fink LN, et al. Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications. Am J Physiol Endocrinol Metab. 2013;304(5):E453–465.
- Rudrapatna S, Bhatt M, Wang K-W, et al. Obesity and muscle-macrophage crosstalk in humans and mice: a systematic review. Obes Rev. 2019;20(11):1572–1596.
- Newman AM, Long Liu C, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–457.
- Ying W, Wenxian F, Sok Lee Y, et al. The role of macrophages in obesity-associated islet inflammation and beta-cell abnormalities. Nat Rev Endocrinol. 2020;16(2):81–90.
- Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425–6440.
- Aron-Wisnewsky J, Tordjman J, Poitou C, et al. Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab. 2009;94(11):4619–4623.
- Bertola A, Ciucci T, Rousseau D, et al. Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes. 2012;61(9):2238–2247.
- Jing M, Jiang T, Tan L, et al. TYROBP in Alzheimer’s disease. Mol Neurobiol. 2015;51(2):820–826.
- Sindhu S, Kochumon S, Shenouda S, et al. The cooperative induction of CCL4 in human monocytic cells by TNF-alpha and palmitate requires MyD88 and involves MAPK/NF-kappaB signaling pathways. Int J Mol Sci. 2019;20(18):4658.
- Dommel S, Blüher. Does C-C motif chemokine ligand 2 (CCL2) link obesity to a pro-inflammatory state? Int J Mol Sci. 2021;22(3):1500.
- Mathews JA, Wurmbrand AP, Ribeiro L, et al. Induction of IL-17A precedes development of airway hyperresponsiveness during diet-induced obesity and correlates with complement factor D. Front Immunol. 2014;5:440.
- Rui X, Ming W, Liu S, et al. Glucose metabolism characteristics and TLR8-mediated metabolic control of CD4(+) treg cells in ovarian cancer cells microenvironment. Cell Death Dis. 2021;12(1):22.
- Acín-Pérez R, Iborra S, Martí-Mateos Y, et al. Fgr kinase is required for proinflammatory macrophage activation during diet-induced obesity. Nat Metab. 2020;2(9):974–988.
- Glowacka WK, Alberts P, Ouchida R, et al. LAPTM5 protein is a positive regulator of proinflammatory signaling pathways in macrophages. J Biol Chem. 2012;287(33):27691–27702.
- Catalán V, Gómez-Ambrosi J, Rodríguez A, et al. Increased levels of calprotectin in obesity are related to macrophage content: impact on inflammation and effect of weight loss. Mol Med. 2011;17(11–12):1157–1167.